{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:44:35Z","timestamp":1780512275728,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81960291"],"award-info":[{"award-number":["No. 81960291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes and Environ"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rheumatoid arthritis (RA) is the most common autoimmune system diseases in our world. More studies in recent years have shown that <jats:italic>FCRL<\/jats:italic> gene polymorphisms is closely related to autoimmune diseases. It is suggested that genetic factors play a crucial role in the pathogenesis of this disease. In this study, we aimed to investigate the relationship between <jats:italic>FCRL1<\/jats:italic> rs2050568, <jats:italic>FCRL3<\/jats:italic> rs2317230 and <jats:italic>FCRL6<\/jats:italic> rs58240276 polymorphisms and RA risk in the Chinese Han population. 506 with RA patients and 509 healthy controls were recruited in this study, and the single nucleotide polymorphisms (SNPs) was successfully genotyped using the Agena MassARRAY platform. Odds ratios (ORs) and 95% confidence intervals (95% CIs) after adjusting for age and gender were conducted to assess these SNPs polymorphisms and RA risk. The multifactor dimensionality reduction (MDR) method was conducted to analyze SNP-SNP interaction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results revealed that there no significant association was observed between the allele and genotype frequencies among these SNPs and RA risk (all <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Straified analysis by age and gender, the results confirmed that <jats:italic>FCRL1<\/jats:italic> rs2050568 T\/T genotype enhanced the risk of RA in females (<jats:italic>p<\/jats:italic>\u2009=\u20090.014). The G\/T - T\/T genotype of <jats:italic>FCRL3<\/jats:italic> rs2317230 was correlated with a decreased RA risk in males (<jats:italic>p<\/jats:italic>\u2009=\u20090.021). We also observed that the C\/T-T\/T genotype of <jats:italic>FCRL6<\/jats:italic> rs58240276 was increased the risk of RA in the group at age\u2009&gt;\u2009\u00a054\u2009years (<jats:italic>p<\/jats:italic>\u2009=\u20090.016). In addition, <jats:italic>FCRL1<\/jats:italic> rs2050568-TT, <jats:italic>FCRL6<\/jats:italic> rs58240276-TT and <jats:italic>FCRL1<\/jats:italic> rs2050568-TT, <jats:italic>FCRL3<\/jats:italic> rs2317230-TT, <jats:italic>FCRL6<\/jats:italic> rs58240276-TT are the best models for multi-site MDR analysis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and the two best models mentioned above and classes RA have the most significant correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study demonstrated that <jats:italic>FCRL1<\/jats:italic> rs2050568, <jats:italic>FCRL3<\/jats:italic> rs2317230, and <jats:italic>FCRL6<\/jats:italic> rs58240276 polymorphisms were correlated with RA susceptibility in the Chinese Han population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41021-021-00213-2","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T13:22:00Z","timestamp":1633612920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fc receptor-like 1, 3, and 6 variants are associated with rheumatoid arthritis risk in the Chinese Han population"],"prefix":"10.1186","volume":"43","author":[{"given":"Yonghui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongya","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-1274","authenticated-orcid":false,"given":"Tianbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"23","key":"213_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319. https:\/\/doi.org\/10.1056\/NEJMra1004965.","journal-title":"N Engl J Med"},{"issue":"3","key":"213_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12253-015-0038-1","volume":"22","author":"B Hu","year":"2016","unstructured":"Hu B, Yan X, Liu F, Zhu C, Zhou H, Chen Y, et al. Downregulated expression of PTPN9 contributes to human hepatocellular carcinoma growth and progression. Pathol Oncol Res. 2016;22(3):555\u201365. https:\/\/doi.org\/10.1007\/s12253-015-0038-1.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"213_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/1756-185X.12966","volume":"21","author":"MY Zhang","year":"2018","unstructured":"Zhang MY, Yang XK, Lv TT, Wu J, Xu SZ, Wang JB, et al. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Int J Rheum Dis. 2018;21(1):179\u201385. https:\/\/doi.org\/10.1111\/1756-185X.12966.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"213_CR4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00296-017-3784-4","volume":"37","author":"G Li","year":"2017","unstructured":"Li G, Zhao J, Li B, Ma J, Zhao Q, Wang X, et al. Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2017;37(10):1673\u201381. https:\/\/doi.org\/10.1007\/s00296-017-3784-4.","journal-title":"Rheumatol Int"},{"issue":"1","key":"213_CR5","doi-asserted-by":"publisher","first-page":"44015","DOI":"10.1038\/srep44015","volume":"7","author":"Q Qiu","year":"2017","unstructured":"Qiu Q, Huang J, Shu X, Fan H, Zhou Y, Xiao C. Polymorphisms and pharmacogenomics for the clinical efficacy of methotrexate in patients with rheumatoid arthritis: a systematic review and Meta-analysis. Sci Rep. 2017;7(1):44015. https:\/\/doi.org\/10.1038\/srep44015.","journal-title":"Sci Rep"},{"issue":"10","key":"213_CR6","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/art.40194","volume":"69","author":"JGC Peeters","year":"2017","unstructured":"Peeters JGC, Vastert SJ, van Wijk F, van Loosdregt J. Review: enhancers in autoimmune arthritis: implications and therapeutic potential. Arthritis Rheumatol. 2017;69(10):1925\u201336. https:\/\/doi.org\/10.1002\/art.40194.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"213_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ng.3603","volume":"48","author":"DL Morris","year":"2016","unstructured":"Morris DL, Sheng Y, Zhang Y, Wang YF, Zhu Z, Tombleson P, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet. 2016;48(8):940\u20136. https:\/\/doi.org\/10.1038\/ng.3603.","journal-title":"Nat Genet"},{"issue":"52","key":"213_CR8","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.1073\/pnas.1520779112","volume":"112","author":"MJ Ombrello","year":"2015","unstructured":"Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, et al. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A. 2015;112(52):15970\u20135. https:\/\/doi.org\/10.1073\/pnas.1520779112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"213_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev.immunol.25.022106.141541","volume":"25","author":"RS Davis","year":"2007","unstructured":"Davis RS. Fc receptor-like molecules. Annu Rev Immunol. 2007;25(1):525\u201360. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141541.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"213_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","volume":"224","author":"M Da\u00ebron","year":"2008","unstructured":"Da\u00ebron M, Jaeger S, du Pasquier L, Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev. 2008;224(1):11\u201343. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00666.x.","journal-title":"Immunol Rev"},{"issue":"6","key":"213_CR11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00262-008-0589-z","volume":"58","author":"T Kazemi","year":"2009","unstructured":"Kazemi T, Asgarian-Omran H, Memarian A, Shabani M, Sharifian RA, Vossough P, et al. Low representation of fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother. 2009;58(6):989\u201396. https:\/\/doi.org\/10.1007\/s00262-008-0589-z.","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"213_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/ijc.23751","volume":"123","author":"T Kazemi","year":"2008","unstructured":"Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifian RA, et al. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer. 2008;123(9):2113\u20139. https:\/\/doi.org\/10.1002\/ijc.23751.","journal-title":"Int J Cancer"},{"issue":"10","key":"213_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10067-012-2028-y","volume":"31","author":"Z Zeng","year":"2012","unstructured":"Zeng Z, Duan Z, Zhang T, Wang S, Li G, Mei Y, et al. Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han population. Clin Rheumatol. 2012;31(10):1449\u201354. https:\/\/doi.org\/10.1007\/s10067-012-2028-y.","journal-title":"Clin Rheumatol"},{"key":"213_CR14","doi-asserted-by":"crossref","unstructured":"Zeng, Z., et al., Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han population. 2012. 31(10): p. 1449\u20131454.","DOI":"10.1007\/s10067-012-2028-y"},{"key":"213_CR15","doi-asserted-by":"crossref","unstructured":"Ombrello, M.J., et al., HLA-DRB1* 11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. 2015. 112(52): p. 15970\u201315975.","DOI":"10.1186\/1546-0096-13-S1-O75"},{"issue":"1","key":"213_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13075-015-0623-4","volume":"17","author":"C Terao","year":"2015","unstructured":"Terao C, Ohmura K, Kochi Y, Ikari K, Okada Y, Shimizu M, et al. Anti-citrullinated peptide\/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population. Arthritis Res Ther. 2015;17(1):104. https:\/\/doi.org\/10.1186\/s13075-015-0623-4.","journal-title":"Arthritis Res Ther"},{"issue":"7488","key":"213_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376\u201381. https:\/\/doi.org\/10.1038\/nature12873.","journal-title":"Nature"},{"issue":"1","key":"213_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10067-015-3105-9","volume":"35","author":"M Jiri","year":"2016","unstructured":"Jiri M, Zhang L, Lan B, He N, Feng T, Liu K, et al. Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population. Clin Rheumatol. 2016;35(1):159\u201363. https:\/\/doi.org\/10.1007\/s10067-015-3105-9.","journal-title":"Clin Rheumatol"},{"issue":"17","key":"213_CR19","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.7314\/APJCP.2014.15.17.7097","volume":"15","author":"X Jin","year":"2014","unstructured":"Jin X, Zhang KJ, Guo X, Myers R, Ye Z, Zhang ZP, et al. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery. Asian Pac J Cancer Prev. 2014;15(17):7097\u2013103. https:\/\/doi.org\/10.7314\/APJCP.2014.15.17.7097.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"213_CR20","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s13277-013-1248-3","volume":"35","author":"QY Hu","year":"2014","unstructured":"Hu QY, Jin TB, Wang L, Zhang L, Geng T, Liang G, et al. Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population. Tumour Biol. 2014;35(3):1863\u20136. https:\/\/doi.org\/10.1007\/s13277-013-1248-3.","journal-title":"Tumour Biol"},{"issue":"2","key":"213_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.rdc.2012.05.001","volume":"38","author":"N Jacob","year":"2012","unstructured":"Jacob N, Jacob CO. Genetics of rheumatoid arthritis: an impressionist perspective. Rheum Dis Clin N Am. 2012;38(2):243\u201357. https:\/\/doi.org\/10.1016\/j.rdc.2012.05.001.","journal-title":"Rheum Dis Clin N Am"},{"key":"213_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/0-387-46530-8_14","volume":"596","author":"GR Ehrhardt","year":"2007","unstructured":"Ehrhardt GR, et al. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv Exp Med Biol. 2007;596:155\u201362. https:\/\/doi.org\/10.1007\/0-387-46530-8_14.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"213_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1055\/s-0035-1545280","volume":"47","author":"D Rostamzadeh","year":"2015","unstructured":"Rostamzadeh D, Dabbaghmanesh M, Shabani M, Hosseini A, Amirghofran Z. Expression profile of human fc receptor-like 1, 2, and 4 molecules in peripheral blood mononuclear cells of patients with Hashimoto's thyroiditis and Graves' disease. Horm Metab Res. 2015;47(9):693\u20138. https:\/\/doi.org\/10.1055\/s-0035-1545280.","journal-title":"Horm Metab Res"},{"issue":"5","key":"213_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ng1540","volume":"37","author":"Y Kochi","year":"2005","unstructured":"Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet. 2005;37(5):478\u201385. https:\/\/doi.org\/10.1038\/ng1540.","journal-title":"Nat Genet"},{"issue":"5","key":"213_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/ard.2005.043489","volume":"65","author":"K Ikari","year":"2006","unstructured":"Ikari K, et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis. 2006;65(5):671\u20133. https:\/\/doi.org\/10.1136\/ard.2005.043489.","journal-title":"Ann Rheum Dis"},{"key":"213_CR26","doi-asserted-by":"crossref","unstructured":"Rostamzadeh, D., et al., Expression profile of human Fc receptor-Like 1, 2, and 4 molecules in peripheral blood mononuclear cells of patients with Hashimoto\u2019s thyroiditis and Graves\u2019 disease. 2015. 47(09): p. 693\u2013698.","DOI":"10.1055\/s-0035-1545280"},{"issue":"9","key":"213_CR27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/ard.2005.048454","volume":"65","author":"A Martinez","year":"2006","unstructured":"Martinez A, Sanchez E, Valdivia A, Orozco G, Lopez-Nevot MA, Pascual-Salcedo D, et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(9):1188\u201391. https:\/\/doi.org\/10.1136\/ard.2005.048454.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"213_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molimm.2012.09.004","volume":"53","author":"J Ramirez-Bello","year":"2013","unstructured":"Ramirez-Bello J, et al. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol. 2013;53(4):374\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2012.09.004.","journal-title":"Mol Immunol"},{"issue":"2","key":"213_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.humimm.2015.12.007","volume":"77","author":"X Lin","year":"2016","unstructured":"Lin X, Zhang Y, Chen Q. FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis. Hum Immunol. 2016;77(2):223\u20139. https:\/\/doi.org\/10.1016\/j.humimm.2015.12.007.","journal-title":"Hum Immunol"}],"container-title":["Genes and Environment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-021-00213-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41021-021-00213-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-021-00213-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T14:05:04Z","timestamp":1633615504000},"score":1,"resource":{"primary":{"URL":"https:\/\/genesenvironment.biomedcentral.com\/articles\/10.1186\/s41021-021-00213-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1186\/s41021-021-00213-2","relation":{},"ISSN":["1880-7062"],"issn-type":[{"value":"1880-7062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case-control study was conducted in accordance with the Declaration of Helsinki. And the protocol was approved by the Ethics Committee of the Xizang Minzu University. Written informed consents were obtained from all individuals. The procedures were in accordance with the institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients agreed to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}